Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.835 |
Intermediate Similarity |
NPD7222 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7453 |
Approved |
0.8261 |
Intermediate Similarity |
NPD7452 |
Approved |
0.8098 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.8019 |
Intermediate Similarity |
NPD4502 |
Phase 2 |
0.7991 |
Intermediate Similarity |
NPD5902 |
Approved |
0.7991 |
Intermediate Similarity |
NPD5903 |
Approved |
0.7982 |
Intermediate Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD3003 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7926 |
Intermediate Similarity |
NPD3875 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD7678 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD6985 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD5658 |
Approved |
0.7767 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD7194 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7756 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7743 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.77 |
Intermediate Similarity |
NPD5530 |
Phase 1 |
0.7685 |
Intermediate Similarity |
NPD5936 |
Approved |
0.7685 |
Intermediate Similarity |
NPD5939 |
Approved |
0.7681 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD5164 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD8395 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8396 |
Approved |
0.7667 |
Intermediate Similarity |
NPD1768 |
Approved |
0.7617 |
Intermediate Similarity |
NPD8403 |
Phase 1 |
0.7583 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.7583 |
Intermediate Similarity |
NPD2177 |
Approved |
0.7583 |
Intermediate Similarity |
NPD2175 |
Phase 3 |
0.7583 |
Intermediate Similarity |
NPD2176 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD7555 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD5256 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD4418 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD8109 |
Clinical (unspecified phase) |
0.7537 |
Intermediate Similarity |
NPD4203 |
Approved |
0.7537 |
Intermediate Similarity |
NPD4204 |
Approved |
0.7523 |
Intermediate Similarity |
NPD3402 |
Phase 1 |
0.7523 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.7523 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.7522 |
Intermediate Similarity |
NPD6977 |
Clinical (unspecified phase) |
0.7522 |
Intermediate Similarity |
NPD4454 |
Phase 2 |
0.7522 |
Intermediate Similarity |
NPD6978 |
Phase 2 |
0.7512 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7511 |
Intermediate Similarity |
NPD6976 |
Clinical (unspecified phase) |
0.7511 |
Intermediate Similarity |
NPD6494 |
Phase 2 |
0.7511 |
Intermediate Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.751 |
Intermediate Similarity |
NPD8364 |
Approved |
0.751 |
Intermediate Similarity |
NPD8363 |
Approved |
0.75 |
Intermediate Similarity |
NPD6290 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6773 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7489 |
Intermediate Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD4039 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4033 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4035 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4122 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4037 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4038 |
Approved |
0.7488 |
Intermediate Similarity |
NPD32 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4034 |
Approved |
0.7488 |
Intermediate Similarity |
NPD31 |
Approved |
0.7488 |
Intermediate Similarity |
NPD4036 |
Approved |
0.7487 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7487 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7475 |
Intermediate Similarity |
NPD6159 |
Phase 2 |
0.7465 |
Intermediate Similarity |
NPD7671 |
Approved |
0.7465 |
Intermediate Similarity |
NPD7672 |
Approved |
0.7449 |
Intermediate Similarity |
NPD8365 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD6456 |
Discontinued |
0.7411 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7401 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7393 |
Intermediate Similarity |
NPD6491 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD8244 |
Phase 2 |
0.7373 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.7364 |
Intermediate Similarity |
NPD6220 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD6991 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6449 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7221 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7219 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD5429 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6717 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD7395 |
Discontinued |
0.7316 |
Intermediate Similarity |
NPD4885 |
Approved |
0.7311 |
Intermediate Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.7311 |
Intermediate Similarity |
NPD8358 |
Approved |
0.7306 |
Intermediate Similarity |
NPD2189 |
Approved |
0.7306 |
Intermediate Similarity |
NPD2187 |
Approved |
0.7304 |
Intermediate Similarity |
NPD5479 |
Discontinued |
0.7304 |
Intermediate Similarity |
NPD7567 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7726 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD6569 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD3006 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD6455 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7269 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.7265 |
Intermediate Similarity |
NPD5417 |
Clinical (unspecified phase) |
0.7265 |
Intermediate Similarity |
NPD6140 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD7659 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD7068 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7067 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5999 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD5632 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4429 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3746 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7232 |
Intermediate Similarity |
NPD6147 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD6643 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD6590 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD5022 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD1322 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6517 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD3514 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD5416 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD8016 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD3478 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD3477 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD8466 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8429 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8467 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8428 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8465 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8427 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD2383 |
Phase 1 |
0.7188 |
Intermediate Similarity |
NPD7538 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7177 |
Intermediate Similarity |
NPD3343 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD6961 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD4795 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD7868 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD6769 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7156 |
Intermediate Similarity |
NPD6965 |
Clinical (unspecified phase) |
0.7155 |
Intermediate Similarity |
NPD5044 |
Phase 2 |
0.7149 |
Intermediate Similarity |
NPD4442 |
Phase 2 |
0.7149 |
Intermediate Similarity |
NPD7853 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7994 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6473 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6716 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7268 |
Clinical (unspecified phase) |
0.7137 |
Intermediate Similarity |
NPD3763 |
Approved |
0.7136 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7131 |
Intermediate Similarity |
NPD8442 |
Discontinued |
0.713 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD2564 |
Approved |
0.7123 |
Intermediate Similarity |
NPD2565 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD4344 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD4343 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD6736 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD1856 |
Discontinued |
0.7116 |
Intermediate Similarity |
NPD5512 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6243 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD8101 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6244 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD7417 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD6750 |
Phase 2 |
0.7085 |
Intermediate Similarity |
NPD6531 |
Approved |
0.7085 |
Intermediate Similarity |
NPD6530 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6988 |
Phase 1 |
0.7082 |
Intermediate Similarity |
NPD5801 |
Clinical (unspecified phase) |
0.7082 |
Intermediate Similarity |
NPD8426 |
Approved |
0.7082 |
Intermediate Similarity |
NPD8460 |
Approved |
0.7082 |
Intermediate Similarity |
NPD8425 |
Approved |
0.7082 |
Intermediate Similarity |
NPD8459 |
Approved |
0.708 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5669 |
Clinical (unspecified phase) |
0.7074 |
Intermediate Similarity |
NPD4881 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD3810 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6553 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD6452 |
Discontinued |
0.7064 |
Intermediate Similarity |
NPD484 |
Approved |
0.7064 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD4890 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7056 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7056
|
Intermediate Similarity |
NPD3921 |
Approved |